|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
SCIDIR_ocn855906890 |
003 |
OCoLC |
005 |
20231117044915.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
130816s2013 ne ob 001 0 eng d |
040 |
|
|
|a IDEBK
|b eng
|e pn
|c IDEBK
|d EBLCP
|d MHW
|d N$T
|d OPELS
|d YDXCP
|d OCLCQ
|d CDX
|d UPM
|d UKDOC
|d GGVRL
|d OCLCQ
|d OCLCF
|d OCLCQ
|d SAV
|d CASUM
|d MERUC
|d U3W
|d D6H
|d AU@
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCO
|d OCLCA
|d OCLCQ
|d S2H
|d OCLCO
|d UKAHL
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9780124159112
|q (electronic bk.)
|
020 |
|
|
|a 0124159117
|q (electronic bk.)
|
020 |
|
|
|a 1299782302
|q (ebk)
|
020 |
|
|
|a 9781299782303
|q (ebk)
|
035 |
|
|
|a (OCoLC)855906890
|
050 |
|
4 |
|a RM315
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.78
|2 23
|
100 |
1 |
|
|a Dargan, Paul I.
|
245 |
1 |
0 |
|a Novel psychoactive substances :
|b classification, pharmacology and toxicology /
|c Paul Dargan, David M. Wood.
|
260 |
|
|
|a Amsterdam ;
|a Boston :
|b Elsevier/Academic Press,
|c �2013.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a Novel Psychoactive Substances: Classification, Pharmacology and Toxicology provides readers with background on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as ""legal highs."" This book also covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance followed by a discussion of the acute and chronic harm or toxicity associated with the substance. Written by international experts in the field, this multi-au.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Section 1. Background -- section 2. Analytical techniques -- section 3. Individual novel psychoactive substances.
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Psychotropic drugs.
|
650 |
|
0 |
|a Psychopharmacology.
|
650 |
|
0 |
|a Substance abuse.
|
650 |
|
0 |
|a Neuropharmacology.
|
650 |
|
0 |
|a Drug testing.
|
650 |
1 |
2 |
|a Psychotropic Drugs
|x pharmacology
|0 (DNLM)D011619Q000494
|
650 |
1 |
2 |
|a Psychotropic Drugs
|x toxicity
|0 (DNLM)D011619Q000633
|
650 |
2 |
2 |
|a Substance Abuse Detection
|0 (DNLM)D015813
|
650 |
2 |
2 |
|a Substance-Related Disorders
|0 (DNLM)D019966
|
650 |
|
2 |
|a Psychotropic Drugs
|0 (DNLM)D011619
|
650 |
|
2 |
|a Psychopharmacology
|0 (DNLM)D011600
|
650 |
|
2 |
|a Neuropharmacology
|0 (DNLM)D009480
|
650 |
|
6 |
|a Psychotropes.
|0 (CaQQLa)201-0001454
|
650 |
|
6 |
|a Psychopharmacologie.
|0 (CaQQLa)201-0020955
|
650 |
|
6 |
|a Polytoxicomanie.
|0 (CaQQLa)000347301
|
650 |
|
6 |
|a Neuropharmacologie.
|0 (CaQQLa)201-0038270
|
650 |
|
6 |
|a Toxicomanie
|x D�epistage.
|0 (CaQQLa)201-0171000
|
650 |
|
6 |
|a Toxicomanie.
|0 (CaQQLa)201-0014203
|
650 |
|
6 |
|a Abus de substances psychoactives.
|0 (CaQQLa)000347291
|
650 |
|
7 |
|a substance abuse.
|2 aat
|0 (CStmoGRI)aat300189230
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Drug testing
|2 fast
|0 (OCoLC)fst00898710
|
650 |
|
7 |
|a Neuropharmacology
|2 fast
|0 (OCoLC)fst01036458
|
650 |
|
7 |
|a Psychopharmacology
|2 fast
|0 (OCoLC)fst01081659
|
650 |
|
7 |
|a Psychotropic drugs
|2 fast
|0 (OCoLC)fst01081826
|
650 |
|
7 |
|a Substance abuse
|2 fast
|0 (OCoLC)fst01136767
|
655 |
|
4 |
|a Internet Resources.
|
700 |
1 |
|
|a Wood, David M.
|
776 |
0 |
8 |
|i Print version:
|a Dargan, Paul.
|t Novel Psychoactive Substances.
|d Elsevier Science & Technology 2013
|z 1299782302
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780124158160
|z Texto completo
|